Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

Minimal residual disease (MRD) before myeloablative hematopoietic cell transplantation (HCT) is associated with adverse outcome in acute myeloid leukemia (AML) in first complete remission (CR1). To compare this association with that for patients in second complete remission (CR2) and to examine the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2013-09, Vol.122 (10), p.1813-1821
Hauptverfasser:	Walter, Roland B., Buckley, Sarah A., Pagel, John M., Wood, Brent L., Storer, Barry E., Sandmaier, Brenda M., Fang, Min, Gyurkocza, Boglarka, Delaney, Colleen, Radich, Jerald P., Estey, Elihu H., Appelbaum, Frederick R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Child Child, Preschool Demography Female Flow Cytometry Graft vs Host Disease - pathology Hematopoietic Stem Cell Transplantation Humans Infant Leukemia, Myeloid, Acute - therapy Male Middle Aged Multivariate Analysis Neoplasm, Residual - pathology Prognosis Proportional Hazards Models Remission Induction Tissue Donors Transplantation Transplantation Conditioning Transplantation, Homologous Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!